Dec 07 2009

Panel Recommends Everolimus in Kidney Transplant

Published by MedPage Today Nephrology at 3:41 pm under Uncategorized

WASHINGTON (MedPage Today) — An FDA advisory panel said the antirejection drug everolimus appears safe and effective for use in kidney transplant patients, but should be marketed with a risk mitigation plan.

Comments Off

Comments are closed at this time.